Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 403

    1.

    The androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriers.

    Spurdle AB, Antoniou AC, Duffy DL, Pandeya N, Kelemen L, Chen X, Peock S, Cook MR, Smith PL, Purdie DM, Newman B, Dite GS, Apicella C, Southey MC, Giles GG, Hopper JL, Chenevix-Trench G, Easton DF; EMBRACE Study Collaborators.

    Breast Cancer Res. 2005;7(2):R176-83. Epub 2004 Dec 16.

    PMID:
    15743497
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat.

    Rebbeck TR, Kantoff PW, Krithivas K, Neuhausen S, Blackwood MA, Godwin AK, Daly MB, Narod SA, Garber JE, Lynch HT, Weber BL, Brown M.

    Am J Hum Genet. 1999 May;64(5):1371-7.

    PMID:
    10205268
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    3.

    Androgen receptor CAG repeat length in Jewish Israeli women who are BRCA1/2 mutation carriers: association with breast/ovarian cancer phenotype.

    Dagan E, Friedman E, Paperna T, Carmi N, Gershoni-Baruch R.

    Eur J Hum Genet. 2002 Nov;10(11):724-8.

    PMID:
    12404104
    [PubMed - indexed for MEDLINE]
    Free Article
    4.

    Breast cancer risk in BRCA1 and BRCA2 mutation carriers and polyglutamine repeat length in the AIB1 gene.

    Hughes DJ, Ginolhac SM, Coupier I, Barjhoux L, Gaborieau V, Bressac-de-Paillerets B, Chompret A, Bignon YJ, Uhrhammer N, Lasset C, Giraud S, Sobol H, Hardouin A, Berthet P, Peyrat JP, Fournier J, Nogues C, Lidereau R, Muller D, Fricker JP, Longy M, Toulas C, Guimbaud R, Yannoukakos D, Mazoyer S, Lynch HT, Lenoir GM, Goldgar DE, Stoppa-Lyonnet D, Sinilnikova OM.

    Int J Cancer. 2005 Nov 1;117(2):230-3.

    PMID:
    15900600
    [PubMed - indexed for MEDLINE]
    5.

    CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers.

    Kadouri L, Easton DF, Edwards S, Hubert A, Kote-Jarai Z, Glaser B, Durocher F, Abeliovich D, Peretz T, Eeles RA.

    Br J Cancer. 2001 Jul 6;85(1):36-40.

    PMID:
    11437399
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    6.

    Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.

    Lose F, Duffy DL, Kay GF, Kedda MA, Spurdle AB; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer; Australian Ovarian Cancer Study Management Group.

    J Natl Cancer Inst. 2008 Nov 5;100(21):1519-29. Epub 2008 Oct 28.

    PMID:
    18957670
    [PubMed - indexed for MEDLINE]
    Free Article
    7.

    Androgen receptor (CAG)n and (GGC)n polymorphisms and breast cancer risk in a population-based case-control study of young women.

    Suter NM, Malone KE, Daling JR, Doody DR, Ostrander EA.

    Cancer Epidemiol Biomarkers Prev. 2003 Feb;12(2):127-35.

    PMID:
    12582022
    [PubMed - indexed for MEDLINE]
    Free Article
    8.

    CAG repeat length in exon 1 of the androgen receptor gene is related to age of diagnosis but not germ line BRCA1 mutation status in ovarian cancer.

    Kim SC, Ju W, Mahavni V, Geisler JP, Buller RE.

    Int J Gynecol Cancer. 2006 Jan-Feb;16 Suppl 1:190-4. Erratum in: Int J Gynecol Cancer. 2006 May-Jun;16(3):1489.

    PMID:
    16515589
    [PubMed - indexed for MEDLINE]
    9.

    The AIB1 glutamine repeat polymorphism is not associated with risk of breast cancer before age 40 years in Australian women.

    Montgomery KG, Chang JH, Gertig DM, Dite GS, McCredie MR, Giles GG, Southey MC, Hopper JL, Campbell IG.

    Breast Cancer Res. 2005;7(3):R353-6. Epub 2005 Mar 4.

    PMID:
    15987430
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    11.

    Polyglutamine repeat length in the AIB1 gene modifies breast cancer susceptibility in BRCA1 carriers.

    Kadouri L, Kote-Jarai Z, Easton DF, Hubert A, Hamoudi R, Glaser B, Abeliovich D, Peretz T, Eeles RA.

    Int J Cancer. 2004 Jan 20;108(3):399-403.

    PMID:
    14648706
    [PubMed - indexed for MEDLINE]
    12.

    Lack of association between androgen receptor CAG polymorphism and familial breast/ovarian cancer.

    Menin C, Banna GL, De Salvo G, Lazzarotto V, De Nicolo A, Agata S, Montagna M, Sordi G, Nicoletto O, Chieco-Bianchi L, D'Andrea E.

    Cancer Lett. 2001 Jul 10;168(1):31-6.

    PMID:
    11368874
    [PubMed - indexed for MEDLINE]
    13.

    A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers.

    Kadouri L, Kote-Jarai Z, Hubert A, Durocher F, Abeliovich D, Glaser B, Hamburger T, Eeles RA, Peretz T.

    Br J Cancer. 2004 May 17;90(10):2002-5.

    PMID:
    15138485
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    14.

    The androgen receptor CAG repeat polymorphism and risk of breast cancer in the Nurses' Health Study.

    Haiman CA, Brown M, Hankinson SE, Spiegelman D, Colditz GA, Willett WC, Kantoff PW, Hunter DJ.

    Cancer Res. 2002 Feb 15;62(4):1045-9.

    PMID:
    11861380
    [PubMed - indexed for MEDLINE]
    Free Article
    15.

    Androgen receptor exon 1 CAG repeat length and breast cancer in women before age forty years.

    Spurdle AB, Dite GS, Chen X, Mayne CJ, Southey MC, Batten LE, Chy H, Trute L, McCredie MR, Giles GG, Armes J, Venter DJ, Hopper JL, Chenevix-Trench G.

    J Natl Cancer Inst. 1999 Jun 2;91(11):961-6.

    PMID:
    10359549
    [PubMed - indexed for MEDLINE]
    Free Article
    16.

    Common BRCA2 variants and modification of breast and ovarian cancer risk in BRCA1 mutation carriers.

    Hughes DJ, Ginolhac SM, Coupier I, Corbex M, Bressac-de-Paillerets B, Chompret A, Bignon YJ, Uhrhammer N, Lasset C, Giraud S, Hardouin A, Berthet P, Peyrat JP, Fournier J, Nogues C, Lidereau R, Muller D, Fricker JP, Longy M, Toulas C, Guimbaud R, Maugard C, Olschwang S, Yannoukakos D, Durocher F, Moisan AM, Simard J, Mazoyer S, Lynch HT, Szabo C, Lenoir GM, Goldgar DE, Stoppa-Lyonnet D, Sinilnikova OM.

    Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):265-7.

    PMID:
    15668505
    [PubMed - indexed for MEDLINE]
    Free Article
    17.

    The CASP8 rs3834129 polymorphism and breast cancer risk in BRCA1 mutation carriers.

    Catucci I, Verderio P, Pizzamiglio S, Manoukian S, Peissel B, Zaffaroni D, Roversi G, Ripamonti CB, Pasini B, Barile M, Viel A, Giannini G, Papi L, Varesco L, Martayan A, Riboni M, Volorio S, Radice P, Peterlongo P.

    Breast Cancer Res Treat. 2011 Feb;125(3):855-60. Epub 2010 Jul 22.

    PMID:
    20652397
    [PubMed - indexed for MEDLINE]
    18.

    Haplotype analysis of TP53 polymorphisms, Arg72Pro and Ins16, in BRCA1 and BRCA2 mutation carriers of French Canadian descent.

    Cavallone L, Arcand SL, Maugard C, Ghadirian P, Mes-Masson AM, Provencher D, Tonin PN.

    BMC Cancer. 2008 Apr 10;8:96.

    PMID:
    18402691
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    19.

    Polymorphic CAG/CAA repeat length in the AIB1/SRC-3 gene and prostate cancer risk: a population-based case-control study.

    Hsing AW, Chokkalingam AP, Gao YT, Wu G, Wang X, Deng J, Cheng J, Sesterhenn IA, Mostofi FK, Chiang T, Chen YL, Stanczyk FZ, Chang C.

    Cancer Epidemiol Biomarkers Prev. 2002 Apr;11(4):337-41.

    PMID:
    11927493
    [PubMed - indexed for MEDLINE]
    Free Article
    20.

    The AIB1 polyglutamine repeat does not modify breast cancer risk in BRCA1 and BRCA2 mutation carriers.

    Spurdle AB, Antoniou AC, Kelemen L, Holland H, Peock S, Cook MR, Smith PL, Greene MH, Simard J, Plourde M, Southey MC, Godwin AK, Beck J, Miron A, Daly MB, Santella RM, Hopper JL, John EM, Andrulis IL, Durocher F, Struewing JP, Easton DF, Chenevix-Trench G; Australian Breast Cancer Family Study; Australian Jewish Breast Cancer Study; Breast Cancer Family Registry; Interdisciplinary Health Research International Team on Breast Cancer Susceptibility; Kathleen Cunningham Foundation Consortium for Research into Familial Breast Cancer; Epidemiological Study of Familial Breast Cancer Study Collaborators.

    Cancer Epidemiol Biomarkers Prev. 2006 Jan;15(1):76-9.

    PMID:
    16434590
    [PubMed - indexed for MEDLINE]
    Free Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk